Comparison of Risk of Re-hospitalization, All-Cause Mortality, and Medical Care Resource Utilization in Patients with Heart Failure and Preserved Versus Reduced Ejection Fraction

American Journal of Cardiology

Volumn 116, Issue 7, 2015, Pages 1088-1092

  Nichols, Gregory A ^a   Reynolds, Kristi ^b   Kimes, Teresa M ^a   Rosales, A Gabriela ^a   Chan, Wing W ^c  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; COMPARATIVE STUDY; DEMOGRAPHY; DIASTOLIC HEART FAILURE; FEMALE; HEALTH CARE UTILIZATION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HOSPITAL READMISSION; HUMAN; ICD-9-CM; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; CAUSE OF DEATH; CLINICAL TRIAL; EPIDEMIOLOGY; FOLLOW UP; HEALTH CARE PLANNING; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TIME; TRENDS; UNITED STATES; UTILIZATION;

AGED; CALIFORNIA; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEALTH RESOURCES; HEART FAILURE; HUMANS; MALE; PATIENT READMISSION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE VOLUME; SURVIVAL RATE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84941189216     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.07.018     Document Type: Article

References (16)

1. F. Bursi, S.A. Weston, M.M. Redfield, S.J. Jacobsen, S. Pakhomov, V.T. Nikomo, R.A. Meverden, and V.L. Roger Systolic and diastolic heart failure in the community JAMA 296 2006 2209 2216
2. M.J. Lenzen, W.J. Scholte op Reimer, E. Boersma, P.J. Vantrimpont, F. Follath, K. Swedberg, J. Cleland, and M. Komajda Differences between patients with a preserved and depressed left ventricular function: a report from the EuroHeart Failure Survey Eur Heart J 25 2004 1214 1220
3. P.A. McCullough, A.K. Khandelwal, J.E. McKinnon, H.J. Shenkman, V. Pampati, D. Nori, R.A. Sullivan, K.R. Sandberg, and S. Kaatz Outcomes and prognostic factors of systolic as compared with diastolic heart failure in urban America Congest Heart Fail 11 2005 6 11
4. N.A. Bello, B. Claggett, A.S. Desai, J.J. McMurray, C.B. Granger, S. Yusuf, K. Swedberg, M.A. Pfeffer, and S.D. Solomon Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction Circ Heart Fail 7 2014 590 595
5. R.S. Vasan, M.G. Larson, E.J. Benjamin, J.C. Evans, C.K. Reiss, and D. Levy Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort J Am Coll Cardiol 33 1999 1948 1955
6. P. Varadarajan, and R.G. Pai Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients J Card Fail 9 2003 107 112
7. L. Liao, J.G. Jollis, K.J. Anstrom, D.J. Whellan, D.W. Kitzman, G.P. Aurigemma, D.B. Mark, K.A. Schulman, and J.S. Gottdiener Costs for heart failure with normal vs reduced ejection fraction Arch Intern Med 166 2006 112 118
8. S. Ather, W. Chan, B. Bozkurt, D. Aguilar, K. Ramasubbu, A.A. Zachariah, X.H. Wehrens, and A. Deswal Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction J Am Coll Cardiol 59 2012 998 1005
9. K. Reynolds, M.G. Butler, T.M. Kimes, A.G. Rosales, W. Chan, and G.A. Nichols Relation of acute heart failure hospital length of stay to subsequent readmission and all-cause mortality Am J Cardiol 116 2015 400 405
10. C. Korves, A. Eldar-Lissai, J. McHale, M.H. Lafeuille, S.H. Ong, and M.S. Duh Resource utilization and costs following hospitalization of patients with chronic heart failure in the US J Med Econ 15 2012 925 937
11. P.A. Heidenreich, J.G. Trogdon, O.A. Khavjou, J. Butler, K. Dracup, M.D. Ezekowitz, E.A. Finkelstein, Y. Hong, S.C. Johnston, A. Khera, D.M. Lloyd-Jones, S.A. Nelson, G. Nichol, D. Orenstein, P.W. Wilson, and Y.J. Woo Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association Circulation 123 2011 933 944
12. D.W. Kitzman, and B. Upadhya Heart failure with preserved ejection fraction: a heterogeneous disorder with multifactorial pathophysiology J Am Coll Cardiol 63 2014 457 459
13. K.F. Adams, G.C. Fonarow, C.L. Emerman, T.H. LeJemtel, M.R. Costanzo, W.T. Abraham, R.L. Berkowitz, M. Galvao, D.P. Horton for the ADHERE Scientific Advisory Committee and Investigators Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 149 2005 209 216
14. J.E. Ho, P. Gona, M.J. Pencina, J.V. Tu, P.C. Austin, R.S. Vasan, W.B. Kannel, R.B. D'Agostino, D.S. Lee, and D. Levy Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community Eur Heart J 33 2012 1734 1741
15. F.P. Brouwers, R.A. de Boer, P. van der Harst, A.A. Voors, R.T. Gansevoort, S.J. Bakker, H.L. Hillege, D.J. van Veldhuisen, and W.H. van Glist Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND Eur Heart J 34 2013 1424 1431
16. D.J. van Veldhuisen, G.C. Linssen, T. Jaarsma, W.H. van Glist, A.W. Hoes, J.G. Tijssen, W.J. Paulus, A.A. Voors, and H.L. Hillege B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction J Am Coll Cardiol 61 2013 1498 1506